Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · IEX Real-Time Price · USD
1.850
-0.030 (-1.60%)
At close: May 8, 2024, 4:00 PM
1.870
+0.020 (1.08%)
After-hours: May 8, 2024, 5:47 PM EDT
Xeris Biopharma Holdings Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for XERS stock have an average target of 4.88, with a low estimate of 4.00 and a high estimate of 6.00. The average target predicts an increase of 163.78% from the current stock price of 1.85.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 28, 2024.
Analyst Ratings
The average analyst rating for XERS stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Initiates $5 | Buy | Initiates | $5 | +170.27% | Mar 28, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $5.5 → $6 | Strong Buy | Maintains | $5.5 → $6 | +224.32% | Mar 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $6 → $5.5 | Strong Buy | Maintains | $6 → $5.5 | +197.30% | Nov 13, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $5 → $4 | Buy | Maintains | $5 → $4 | +116.22% | Nov 10, 2023 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $4.5 | Strong Buy | Initiates | $4.5 | +143.24% | Aug 28, 2023 |
Financial Forecast
Revenue This Year
188.12M
from 163.91M
Increased by 14.77%
Revenue Next Year
223.72M
from 188.12M
Increased by 18.92%
EPS This Year
-0.39
from -0.45
EPS Next Year
-0.22
from -0.39
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 203.9M | 241.9M | 283.3M | 332.6M | 377.6M |
| Avg | 188.1M | 223.7M | 263.9M | 312.5M | 358.0M |
| Low | 173.2M | 191.3M | 236.2M | 293.7M | 335.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 24.4% | 28.6% | 26.6% | 26.1% | 20.8% |
| Avg | 14.8% | 18.9% | 18.0% | 18.4% | 14.6% |
| Low | 5.6% | 1.7% | 5.6% | 11.3% | 7.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.30 | -0.14 | 0.27 | 0.49 | 0.69 |
| Avg | -0.39 | -0.22 | 0.07 | 0.40 | 0.51 |
| Low | -0.46 | -0.34 | -0.05 | 0.24 | 0.33 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 633.1% | 72.0% |
| Avg | - | - | - | 498.5% | 26.6% |
| Low | - | - | - | 249.4% | -17.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.